IL-31 Rabbit Polyclonal Antibody
To Order Contact Us Below:
IL-31 Antibody |
3745-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development. |
IL-31 Antibody |
3747-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development. |
IL-31 Antibody |
3747-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development. |
IL-31 Antibody |
24390-100ul |
SAB |
100ul |
EUR 468 |
IL-31 Antibody |
24391-100ul |
SAB |
100ul |
EUR 468 |
Rabbit IL-31 ELISA Kit |
ERTI0041 |
Abclonal |
96Tests |
EUR 625.2 |
IL-31 |
E21-053 |
EnoGene |
10ug |
EUR 411.6 |
Anti-IL-31 Antibody |
A08339-1 |
BosterBio |
100ug/vial |
EUR 400.8 |
Anti-IL-31 antibody |
STJ98951 |
St John's Laboratory |
200 µl |
EUR 236.4 |
Description: Rabbit polyclonal to IL-31. |
XMIRXpress lentivector miRNA-31-5p with Xmotif |
XMIRXP-31 |
SBI |
10 ug |
EUR 812.4 |
|
IL-31, Interleukin-31, human |
RC212-42 |
Bio Basic |
2ug |
EUR 125.26 |
|
IL-31 Peptide |
3745P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) IL-31 peptide |
IL-31 Peptide |
3747P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) IL-31 peptide |
Recombinant Human Interleukin-31/IL-31 |
C053-10ug |
Novoprotein |
10ug |
EUR 242.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Human Interleukin-31/IL-31 |
C053-1mg |
Novoprotein |
1mg |
EUR 3774 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Human Interleukin-31/IL-31 |
C053-500ug |
Novoprotein |
500ug |
EUR 2660.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Human Interleukin-31/IL-31 |
C053-50ug |
Novoprotein |
50ug |
EUR 595.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
IL-20, Interleukin-20, human |
RC212-31 |
Bio Basic |
2ug |
EUR 125.26 |
|
Anti-IL-31 alpha antibody |
STJ96456 |
St John's Laboratory |
200 µl |
EUR 236.4 |
Description: Rabbit polyclonal to IL-31Ralpha. |
Anti-human IL-31 antibody |
STJ15100124 |
St John's Laboratory |
500 µg |
EUR 632.4 |
Description: This monoclonal antibody is recommended for neutralization of human IL-31 bioactivity. |
Anti-human IL-31 antibody |
STJ15100125 |
St John's Laboratory |
250 µg |
EUR 403.2 |
Description: These monoclonal antibodies enable sensitive and specific detection of human IL-31 in immunoassays such as ELISA and ELISpot. |
Anti-human IL-31 antibody |
STJ15100126 |
St John's Laboratory |
250 µg |
EUR 440.4 |
Description: This monoclonal antibody enables sensitive and specific detection of human IL-31 in immunoassays such as ELISA and ELISpot. |
IL-31 Recombinant Protein |
40-272-0002mg |
ProSci |
0.002 mg |
EUR 311.1 |
Description: Human IL-31 is a T-cell derived cytokine that shares several structural and functional characteristics with IL-6, Oncostatin M, LIF, and Cardiotrophin-1. It signals through a receptor complex comprised of GPL (GP130-like, IL-31RA) and OSMR (Oncostatin M receptor). GPL/OSMR signaling is a strong activator of STAT3 and STAT5, and can also activate STAT1, Jak1, and Jak2 signaling pathways. IL-31 regulated immune responses have been implicated in skin physiology and inflammatory skin diseases. Recombinant IL-31 is a 15.8 kDa protein containing 141 amino acid residues. |
IL-31 Rabbit Polyclonal Antibody